Viewing Study NCT00841035

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:36 PM

Ignite Modification Date: 2025-12-25 @ 8:07 PM

Study NCT ID: NCT00841035

Status: TERMINATED

Last Update Posted: 2017-05-19

First Post: 2009-02-09

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients

Sponsor: University of Alabama at Birmingham

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module